ORAMED PHARMACEUTICALS INC's ticker is ORMP and the CUSIP is 68403P203. A total of 104 filers reported holding ORAMED PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.40 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $665,451 | +44.7% | 55,316 | -22.1% | 0.00% | 0.0% |
Q3 2022 | $460,000 | +15.9% | 70,965 | -18.1% | 0.00% | 0.0% |
Q2 2022 | $397,000 | +194.1% | 86,676 | +455.6% | 0.00% | – |
Q1 2022 | $135,000 | -83.5% | 15,600 | -58.2% | 0.00% | -100.0% |
Q3 2021 | $820,000 | +343.2% | 37,285 | +170.2% | 0.00% | +200.0% |
Q2 2021 | $185,000 | – | 13,800 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MORGAN JESS S & CO INC | 315,301 | $1,444,000 | 1.50% |
Private Portfolio Partners LLC | 54,010 | $247,366 | 0.07% |
Knoll Capital Management, LLC | 20,000 | $92,000 | 0.05% |
Urban Wealth Management, LLC | 2,858 | $13,000 | 0.04% |
OCCUDO QUANTITATIVE STRATEGIES LP | 100,216 | $459,000 | 0.04% |
XTX Topco Ltd | 18,174 | $83,000 | 0.03% |
Rossmore Private Capital | 40,661 | $186,000 | 0.03% |
Ergoteles LLC | 224,700 | $1,029,000 | 0.03% |
ETF MANAGERS GROUP, LLC | 87,365 | $393,000 | 0.01% |
Belvedere Trading LLC | 40,690 | $343,000 | 0.01% |